DÄ internationalArchiveReferences
References

Original article

Renal Insufficiency and Medication in Nursing Home Residents

Dtsch Arztebl Int 2016; 113: 92-8. DOI: 10.3238/arztebl.2016.0092

Hoffmann, F; Boeschen, D; Dörks, M; Herget-Rosenthal, S; Petersen, J; Schmiemann, G

1.Pflegestatistik 2011. Pflege im Rahmen der Pflegeversicherung. Deutschlandergebnisse www.destatis.de/DE/Publikationen/Thematisch/Gesundheit/PflegePflegeDeutschlandergebnisse5224001119004.pdf ] (Last accessed on 28 September 2015).
2.Reuther S, van Nie N, Meijers J, Halfens R, Bartholomeyczik S: [Malnutrition and dementia in the elderly in German nursing homes. Results of a prevalence survey from the years 2008 and 2009]. Z Gerontol Geriatr 2013; 46: 260–7 CrossRef MEDLINE
3.Meyer G, Köpke S, Haastert B, Mühlhauser I: Restraint use among nursing home residents: cross-sectional study and prospective cohort study. J Clin Nurs 2009; 18: 981–90 CrossRef MEDLINE
4.Hoffmann F, Kaduszkiewicz H, Glaeske G, van den Bussche H, Koller D: Prevalence of dementia in nursing home and community-dwelling older adults in Germany. Aging Clin Exp Res 2014; 26: 555–9 CrossRef MEDLINE
5.Richter T, Mann E, Meyer G, Haastert B, Köpke S: Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. J Am Med Dir Assoc 2012; 13: 187.e7–187.e13 CrossRef MEDLINE
6.Gordon AL, Franklin M, Bradshaw L, Logan P, Elliott R, Gladman JRF: Health status of UK care home residents: a cohort study.
Age Ageing 2014; 43: 97–103 CrossRef MEDLINE PubMed Central
7.Aguilar EA, Ashraf H, Frontini M, Ruiz M, Reske TM, Cefalu C: An analysis of chronic kidney disease risk factors in a Louisiana nursing home population: a cross-sectional study. J La State Med Soc 2013; 165: 260–3, 265–7 MEDLINE
8.Chan TC, Yap DYH, Shea YF, Luk KH, Chan HW, Chu LW: Prevalence and associated comorbidities of moderate to severe chronic renal impairment in Chinese nursing home older adults. J Am Med Dir Assoc 2012; 13: 630–3 CrossRefMEDLINE
9.Joseph J, Koka M, Aronow WS: Prevalence of moderate and severe renal insufficiency in older persons with hypertension, diabetes mellitus, coronary artery disease, peripheral arterial disease, ischemic stroke, or congestive heart failure in an academic nursing home. J Am Med Dir Assoc 2008; 9: 257–9 CrossRef MEDLINE
10.Schnelle J, Osterweil D, Globe D, Sciarra A, Audhya P, Barlev A: Chronic kidney disease, anemia, and the association between chronic kidney disease-related anemia and activities of daily living in older nursing home residents. J Am Med Dir Assoc 2009; 10: 120–6 CrossRef MEDLINE
11.Garg AX, Papaioannou A, Ferko N, Campbell G, Clarke JA, Ray JG: Estimating the prevalence of renal insufficiency in seniors requiring long-term care. Kidney Int 2004; 65: 649–53 CrossRef MEDLINE
12.Robinson B, Artz AS, Culleton B, Critchlow C, Sciarra A, Audhya P: Prevalence of anemia in the nursing home: contribution of chronic kidney disease. J Am Geriatr Soc 2007; 55: 1566–70 CrossRef MEDLINE
13.Beloosesky Y, Nenaydenko O, Gross Nevo RF, Adunsky A, Weiss A: Rates, variability, and associated factors of polypharmacy in nursing home patients. Clin Interv Aging 2013; 8: 1585–90 CrossRef MEDLINE PubMed Central
14.Hartmann B, Czock D, Keller F: Drug therapy in patients with chronic renal failure. Dtsch Arztebl Int 2010; 107: 647–55; quiz 655–6 VOLLTEXT
15. Gurwitz JH, Field TS, Harrold LR, et al.: Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107–16 CrossRef MEDLINE
16.Jaehde U, Thürmann PA: [Medication safety in nursing homes]. Z Evid Fortbild Qual Gesundhwes 2012; 106: 712–6 CrossRefMEDLINE
17.Gurwitz JH, Field TS, Avorn J, et al.: Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 87–94 CrossRef
18.Hanlon JT, Wang X, Handler SM, et al.: Potentially inappropriate prescribing of primarily renally cleared medications for older veterans affairs nursing home patients. J Am Med Dir Assoc 2011; 12: 377–83 CrossRef MEDLINE PubMed Central
19.Rahimi AR, Kennedy K, Thomason M, Crumley J, Bugg A, Peacock E: Improper renal dosing in long-term care facilities. South Med J 2008; 101: 802–5 CrossRef MEDLINE
20. Papaioannou A, Clarke JA, Campbell G, Bédard M: Assessment of adherence to renal dosing guidelines in long-term care facilities. J Am Geriatr Soc 2000; 48: 1470–3 CrossRef
21.Schaeffner ES, Ebert N, Delanaye P, et al.: Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012; 157: 471–81 CrossRef MEDLINE
22.Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ: Patterns of intra-cluster correlation from primary care research to inform study design and analysis.
J Clin Epidemiol 2004; 57: 785–94 CrossRef MEDLINE
23.Modig S, Lannering C, Östgren C, Mölstad S, Midlöv P: The assessment of renal function in relation to the use of drugs in elderly in nursing homes; a cohort study. BMC Geriatr 2011; 11: 1 CrossRef MEDLINE PubMed Central
24.Dharmarajan TS, Yoo J, Russell RO, Norkus EP: Chronic kidney disease staging in nursing home and community older adults: does the choice of cockcroft-gault, modification of diet in renal disease study, or the chronic kidney disease epidemiology collaboration initiative equations matter? J Am Med Dir Assoc 2012; 13: 151–5 CrossRef MEDLINE
25.Karsch-Völk M, Schmid E, Wagenpfeil S, Linde K, Heemann U, Schneider A: Kidney function and clinical recommendations of drug dose adjustment in geriatric patients. BMC Geriatr 2013; 13: 92 CrossRef MEDLINE PubMed Central
26.Drenth-van Maanen AC, Jansen PA, Proost JH, Egberts TC, van Zuilen AD, van der Stap D, van Marum RJ: Renal function assessment in older adults. Br J Clin Pharmacol 2013; 76: 616–23 CrossRef
27.Nygaard HA, Naik M, Ruths S, Krüger K: Clinically important renal impairment in various groups of old persons. Scand J Prim Health Care 2004; 22: 152–6 CrossRef
28.Dowling TC, Wang ES, Ferrucci L, Sorkin JD: Glomerular filtration rate equations overestimate creatinine clearance in older individuals enrolled in the Baltimore Longitudinal Study on Aging: impact on renal drug dosing. Pharmacotherapy 2013; 33: 912–21 CrossRef MEDLINE PubMed Central
29.Khanal A, Castelino RL, Peterson GM, Jose MD: Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources? Intern Med J 2014; 44: 77–85 CrossRef MEDLINE
30.Hanlon JT, Aspinall SL, Semla TP, et al.: Consensus guidelines for oral dosing of primarily renally cleared medications in older adults. J Am Geriatr Soc 2009; 57: 335–40 CrossRef MEDLINE PubMed Central
31. Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK: Metformin in patients with type 2 diabetes and kidney disease:
A systematic review. JAMA 2014; 312: 2668–75 CrossRef MEDLINE PubMed Central
32.Rutkowski B, Tylicki L: Nephroprotective action of renin-angiotensin-aldosterone system blockade in chronic kidney disease patients: the landscape after ALTITUDE and VA NEPHRON-D trails.
J Ren Nutr 2015; 25: 194–200 CrossRef MEDLINE
33.Verbeke F, Lindley E, van Bortel L, et al.: A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant 2014; 29: 490–6 CrossRef MEDLINE
34.National Institute for Health and Care Excellence: Anaemia management in people with chronic kidney disease. London: National Clinical Guideline Centre www.nice.org.uk/guidance/ng8 ]; 2015 (last accessed on 28 September 2015).
35.Bundesministerium für Gesundheit: Aktionsplan 2008/2009 Zur Verbesserung Der Arzneimitteltherapiesicherheit (AMTS) in Deutschland [www.akdae.de/AMTS/Aktionsplan/Aktionsplan-AMTS-2008–2009.pdf]; 2007 (last accessed on 28 September 2015).
36.Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP): Verminderde Nierfunctie; Doseringsadviezen Voor Geneesmiddelen. Den Haag: Geneesmiddel Informatie Centrum www.knmp.nl/downloads/TabelbijVerminderdenierfunctie.Doseringsadviezenvoorgeneesmiddelen.pdf/view
(last accessed on 28 September 2015).
e1.Todd A, Holmes HM: Recommendations to support deprescribing medications late in life. Int J Clin Pharm 2015; 37: 678–81 CrossRef MEDLINE
e2.Schwartz JB: Primary prevention: do the very elderly require a different approach? Trends Cardiovasc Med 2015; 25: 228–39 CrossRef MEDLINE
e3.Kutner JS, Blatchford PJ, Taylor DH, et al.: Safety and benefit of discontinuing statin therapy in the setting of advanced,
life-limiting illness. JAMA Intern Med 2015; 175: 691–700 CrossRef MEDLINE PubMed Central
e4.Schaeffner ES, Ebert N, Delanaye P, et al.: Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012; 157: 471–81 CrossRef MEDLINE